Corporate Banner
Satellite Banner
Metabolomics & Lipidomics
Scientific Community
Become a Member | Sign in
Home>News>This Article

PREMIER Biosoft and JEOL Enter Agreement

Published: Thursday, June 06, 2013
Last Updated: Thursday, June 06, 2013
Bookmark and Share
The co-marketing agreement aims to advance research involving marker studies, drug metabolite profiling, lipid and proteomics analysis using MALDI-IMS technology.

PREMIER Biosoft and JEOL announce that they have signed a co-marketing agreement for MALDIVision, a MALDI Imaging Mass Spectrometry (MALDI IMS) data analysis tool. The collaboration aims to provide a comprehensive tool for advancing research involving marker studies, drug metabolite profiling, lipid and proteomics analysis using MALDI-IMS technology. Under this agreement, JEOL will promote MALDIVision along with its JMS-S3000 SpiralTOF™ Matrix Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometer.

MALDIVision visualizes and analyzes spatial distribution of analytes in a sampled tissue section. MALDIVision is the only tool on the market to seamlessly load and analyze imaging data files up to 20 GB. The program generates high quality reconstituted MALDI images in 2D and 3D based on the m/z value of target compounds. Users can overlay up to 10 MALDI images for visualization of spatial distribution of different compounds present in a sample.

According to Yoshihisa Ueda, the general manager of the Mass Spectrometry Business Unit JEOL Ltd., “Our JMS-S3000 SpiralTOF™ has the highest mass resolving power among any MALDI-TOFMS on the market. This imposes a unique challenge to the imaging data analysis software; the amount of information and, thus, the size of the imaging data from SpiralTOF is also the largest. After rigorous evaluation, we found that MALDIVision can process such data flawlessly. We are quite excited that, by combining SpiralTOF and MALDIVision, now we can offer a powerful and unique solution for the cutting edge research in life science and material science.”

“Mass Spectrometry is a rapidly growing platform for biomarker discovery. This collaboration will provide the research community, especially in the Asia-Pacific region, with a powerful tool to support mass spectrometry based imaging applications,” said Arun Apte, CEO at PREMIER Biosoft.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Dr. Vladimir Shulaev Joins PREMIER Biosoft Scientific Advisory Board
Dr. Shulaev joins SAB to further the development of software solutions for metabolomics and lipidomics research.
Saturday, September 19, 2015
PREMIER Biosoft Announces Collaboration with University of Utah
Formal collaboration to advance metabolomics and lipidomics research.
Friday, August 07, 2015
Scientific News
Gut Microbes Signal to the Brain When They're Full
Don't have room for dessert? The bacteria in your gut may be telling you something.
Turning up the Tap on Microbes Leads to Better Protein Patenting
Mining millions of proteins could become faster and easier with a new technique that may also transform the enzyme-catalyst industry, according to University of California, Davis, researchers.
Drug May Prevent Life-Threatening Muscle Loss in Advanced Cancers
New data describes how an experimental drug can stop life-threatening muscle wasting (cachexia) associated with advanced cancers and restore muscle health.
Cancer-Fighting Tomato Component Traced
The metabolic pathway associated with lycopene, the bioactive red pigment found in tomatoes, has been traced by researchers at the University of Illinois.
Circadian Clock Controls Insulin and Blood Sugar in Pancreas
Map of thousands of genes suggests new therapeutic targets for diabetes.
Cellular Stress Process Identified in Cardiovascular Disease
Combining the investigative tools of genetics, transcriptomics, epigenetics and metabolomics, a Duke Medicine research team has identified a new molecular pathway involved in heart attacks and death from heart disease.
Predicting Adverse Drug Reactions with Higher Confidence
A new integrated computational method helps predicting adverse drug reaction—which are often lethal—more reliably than with traditional computing methods.
A New Way to Starve Lung Cancer?
Metabolic alterations in lung cancer may open new avenues for treating the disease.
Evidence of How Incurable Cancer Develops
Researchers in the West Midlands have made a breakthrough in explaining how an incurable type of blood cancer develops from an often symptomless prior blood disorder.
Building a Better Liposome
Computational models suggest new design for nanoparticles used in targeted drug delivery.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos